Opinions of the UK general public in using artificial intelligence and opt-out models of consent in medical research

William Heseltine-Carp,Mark Thurston,Michael Allen,Daniel Browning,Megan Courtman,Aishwarya Kasabe,Emmanuel Ifeachor,Stephen Mullin
DOI: https://doi.org/10.1101/2024.12.13.24318727
2024-12-14
Abstract:Background Due to its complexity, Artificial Intelligence often requires large, confidential clinical datasets. 20-30% of the general public remain sceptical of Artificial Intelligence in healthcare due to concerns of data security, patient-practitioner communication, and commercialisation of data/models to third parties. A better understanding of public concerns of Artificial Intelligence is therefore needed, especially in the context of stroke research. Aims We aimed to evaluate the opinion of patients and the public in acquiring large clinical datasets using an opt-out consent model, in order to train an AI-based tool to predict the future risk of stroke from routine healthcare data. This was in the context of our project ABSTRACT, a UK Medical Research Council study which aims to use AI to predict future risk of stroke from routine hospital data. Methods Opinions were gathered from those with lived experience of stroke/TIA, caregivers, and the general public through an online survey, semi-structured focus groups, and 1:1 interviews. Participants were asked about their perceived importance of the project, the acceptability of handling deidentified routine healthcare data without explicit consent, and the acceptability of acquiring these data via an opt-out model of consent model by members within and outside of the routine clinical care team. Results Of the 83 that participated, 34% of which had a history of stroke/TIA. Nearly all (99%) supported the project's aims in using AI to predict stroke risk, acquiring data via an opt-out consent model, and the handling of pseudonymized data by members within and outside of the routine clinical care team. Conclusion Both the general public and those with lived experience of stroke/TIA are generally supportive of using large, de-identified medical datasets to train AI models for stroke risk prediction under an opt-out consent model, provided the research is transparent, ethically sound, and beneficial to public health.
What problem does this paper attempt to address?